3811-04-9
CAS 3811-04-9
3811-04-9 (CAS 3811-04-9) is a pharmaceutical compound with 0 bioactivity targets and 776 adverse event associations.
Compound Identity
Matched identifiers and naming fields for the pharmaceutical compound record.
Cross-Reference to Cosmetics
Same-CAS ingredient record found in the cosmetics vertical.
Drug Names / RxNorm
Normalized drug-name vocabulary rows, RxCUIs, and source abbreviations.
| Name | RxCUI | Type | Source |
|---|---|---|---|
| POTASSIUM CHLORATE | 59203 | SU | MTHSPL |
Frequently Asked Questions
Short answers generated only from the same visible source-linked rows on this page.
What is 3811-04-9 used for in pharmaceutical contexts?
3811-04-9 (CAS 3811-04-9) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.
What are the known adverse events for 3811-04-9?
3811-04-9 has 776 DrugCentral/FAERS adverse event associations. Rendered reaction terms include Abdominal distension, Abdominal pain, Abdominal pain upper, Activated partial thromboplastin time prolonged, Adrenal disorder. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.
Is 3811-04-9 also used in cosmetics?
Yes. The ingredients table has a same-CAS cosmetic profile for Potassium Chlorate with EU status "restricted".
What clinical phase is 3811-04-9 in?
No phase 1-4 clinical development badge is rendered for 3811-04-9 because the matched compound identifier rows do not contain a max-phase value.